Foundation Medicine Secures $42,500,000 Series B Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8762ba46-9d11-4175-ab0e-f87effe6343c&Preview=1 -
Date
9/21/2012 -
Company Name
Foundation Medicine -
Mailing Address
One Kendall Square Boston, MA 02139 -
Company Description
The trick to beating cancer could be a single test that shows all known genetic traits in each person’s tumor, and that also matches those results to the best treatments. -
Website
http://www.foundationmedicine.com -
Transaction Type
Venture Equity -
Transaction Amount
$42,500,000 -
Transaction Round
Series B -
Proceeds Purposes
The proceeds from the financing will help Foundation Medicine expand commercial operations, scale laboratory capabilities and develop additional genomic profiling and information services. -
M&A Terms
-
Venture Investor
Deerfield Capital -
Venture Investor
Casdin Capital -
Venture Investor
Redmile Group -
Venture Investor
Roche Venture Fund -
Venture Investor
WuXi PharmaTech -
Venture Investor
Third Rock Ventures -
Venture Investor
Google Ventures -
Venture Investor
Kleiner Perkins Caufield & Byers
